
Progressive endothelin-1 gene activation initiates chronic/end-stage renal disease following experimental ischemic/reperfusion injury
Keywords: Atrasentan; BQ-788; endothelin-1; endothelin-1 receptor A; endothelin-1 receptor B; epigenetic modifications